Astrazeneca-Phar Stock/Share Prices, Buy and Sell Astrazeneca-Phar BSE Stocks

Astrazeneca Pharma India Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

23 Sep 2019 | 10:10 AM

2,117.30

68.55 (3.35%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

22.81%

Return (1Y)

Beaten S&P BSE Healthcare by 39.31%
More Volatile

2.55%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.53%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

2,399

1,307

News & Announcements

Astrazeneca Pharma India appoints director
45 days ago

Astrazeneca Pharma India appoints director

08 - Aug - 2019 12:00 AM | 45 days ago

Astrazeneca Pharma India has appointed Narayan K Seshadri (DIN: 00053563) as Independent Director for a 2nd term of 5 years i.e., with effect from 30 September 2019 to 29 September 2024.
Powered by Capital Market - Live News
Astrazeneca Pharma India fixes record date for interim dividend
46 days ago

Astrazeneca Pharma India fixes record date for interim dividend

08 - Aug - 2019 12:00 AM | 46 days ago

Astrazeneca Pharma India has fixed 21 August 2019 as record date for payment of interim dividend. The dividend will be paid/dispatched to the shareholders on or before 04 September 2019.
Powered by Capital Market - Live News
Board of Astrazeneca Pharma India recommends Interim Dividend
46 days ago

Board of Astrazeneca Pharma India recommends Interim Dividend

08 - Aug - 2019 12:00 AM | 46 days ago

Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 07 August 2019, has recommended a Interim dividend of Rs.1 per share (i.e.50%), subject to the approval of the shareholders.
Powered by Capital Market - Live News
Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
46 days ago

Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter

07 - Aug - 2019 12:00 AM | 46 days ago

Net profit of Astrazeneca Pharma India rose 236.78% to Rs 21.52 crore in the quarter ended June 2019 as against Rs 6.39 crore during the previous quarter ended June 2018. Sales rose 26.71% to Rs 204.56 crore in the quarter ended June 2019 as against Rs 161.44 crore during the previous quarter ended June 2018.
Particulars Quarter Ended
Jun. 2019 Jun. 2018 % Var.
Sales 204.56 161.44 27
OPM % 17.39 5.74 -
PBDT 38.27 12.69 202
PBT 33.64 9.14 268
NP 21.52 6.39 237
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Astrazeneca Pharma India Ltd has increased by 28.2% since past 3 Months
MF shareholding in Astrazeneca Pharma India Ltd has decreased by -13.42% since past 3 Months
FII shareholding in Astrazeneca Pharma India Ltd has increased by 381.28% since past 1 Year
MF shareholding in Astrazeneca Pharma India Ltd has decreased by -36.17% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2019	Jun. 2018	% Var.
Sales	204.56	161.44	27
OPM %	17.39	5.74	-
PBDT	38.27	12.69	202
PBT	33.64	9.14	268
NP	21.52	6.39	237

General Notifications

My Notifications

Research Notifications

Astrazeneca Pharma India Ltd NSE / BSE Pharmaceuticals, Mid Cap

2,117.30 68.55 (3.35%)

News & Announcements

Price vs Volume

Stock Trivia

Astrazeneca Pharma India Ltd NSE / BSE
Pharmaceuticals, Mid Cap

2,117.30

68.55 (3.35%)